☰

Tanushree Ganguly, Ph.D. - Publications

Affiliations: 
2013 Chemistry Washington State University, Pullman, WA, United States 
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hausner SH, Bauer N, Davis RA, Ganguly T, Tang SYC, Sutcliffe JL. The Effects of an Albumin Binding Moiety on the Targeting and Pharmacokinetics of an Integrin αβ-Selective Peptide Labeled with Aluminum [F]Fluoride. Molecular Imaging and Biology. PMID 32383076 DOI: 10.1007/S11307-020-01500-0  0.306
2020 Ganguly T, Tang SY, Bauer N, Sutcliffe JL. Evaluation of Two Optical Probes for Imaging the Integrin αβ- In Vitro and In Vivo in Tumor-Bearing Mice. Molecular Imaging and Biology. PMID 32002763 DOI: 10.1007/S11307-019-01469-5  0.335
2016 Dannoon S, Ganguly T, Cahaya H, Geruntho JJ, Galliher MS, Beyer SK, Choy CJ, Hopkins MR, Regan M, Blecha JE, Skultetyova L, Drake CR, Jivan S, Barinka C, Jones EF, et al. Structure-Activity Relationship of 18F-labeled phosphoramidate peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-targeted inhibitor analogues for PET imaging of prostate cancer. Journal of Medicinal Chemistry. PMID 27228467 DOI: 10.1021/Acs.Jmedchem.5B01850  0.72
2015 Nedrow JR, Latoche JD, Day KE, Modi J, Ganguly T, Zeng D, Kurland BF, Berkman CE, Anderson CJ. Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 26552656 DOI: 10.1007/S11307-015-0908-7  0.72
2015 Ganguly T, Dannoon S, Hopkins MR, Murphy S, Cahaya H, Blecha JE, Jivan S, Drake CR, Barinka C, Jones EF, VanBrocklin HF, Berkman CE. A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer. Nuclear Medicine and Biology. PMID 26169882 DOI: 10.1016/J.Nucmedbio.2015.06.003  0.747
2014 Martin SE, Ganguly T, Munske GR, Fulton MD, Hopkins MR, Berkman CE, Black ME. Development of inhibitor-directed enzyme prodrug therapy (IDEPT) for prostate cancer. Bioconjugate Chemistry. 25: 1752-60. PMID 25157916 DOI: 10.1021/Bc500362N  0.706
2013 Nedrow-Byers JR, Moore AL, Ganguly T, Hopkins MR, Fulton MD, Benny PD, Berkman CE. PSMA-targeted SPECT agents: mode of binding effect on in vitro performance. The Prostate. 73: 355-62. PMID 22911263 DOI: 10.1002/Pros.22575  0.667
2012 Nedrow-Byers JR, Jabbes M, Jewett C, Ganguly T, He H, Liu T, Benny P, Bryan JN, Berkman CE. A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agent. The Prostate. 72: 904-12. PMID 22670265 DOI: 10.1002/Pros.21493  0.678
2011 Ganguly T, Kasten BB, Buar DK, MacGillivray LR, Berkman CE, Benny PD. The hydrazide/hydrazone click reaction as a biomolecule labeling strategy for M(CO) 3 (M = Re, 99mTc) radiopharmaceuticals Chemical Communications. 47: 12846-12848. PMID 22044929 DOI: 10.1039/C1Cc15451F  0.533
Show low-probability matches.